In a phase 3 trial, Axpaxli, a tyrosine kinase inhibitor, achieved its superiority primary endpoint vs. aflibercept for the treatment of wet age-related macular degeneration, according to a press ...
February 16, 2026: We're on the hunt for new Tap Simulator codes for the big Valentine's Day update. What are the latest Tap Simulator codes? If you're looking to ease the pressure on your mouse, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results